Is polycystic ovary syndrome an exception for reproductive aging?

Author： Ramezani Tehrani Fahimeh   Solaymani-Dodaran Masoud   Hedayati Mehdi   Azizi Fereidoun  

Publisher： Oxford University Press

ISSN： 1460-2350

Source： Human Reproduction, Vol.25, Iss.7, 2010-07, pp. : 1775-1781

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thiazolidinediones for the Therapeutic Management of Polycystic Ovary Syndrome: Impact on Metabolic and Reproductive Abnormalities

By Elkind-Hirsch Karen E.  

Treatments in Endocrinology, Vol. 5, Iss. 3, 2006-01 ,pp. : 171-187

Adis International

Access to resources Recommend Favorite

Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects

By Nardo L. G.   Rai R.  

Gynecological Endocrinology, Vol. 15, Iss. 5, 2001-10 ,pp. : 373-380

Informa Healthcare

Access to resources Recommend Favorite

Prevalence of polycystic ovary syndrome in reproductive-aged women with type 2 diabetes

By Amini Massoud   Horri Negar   Farmani Mahboubeh   Haghighi Sassan   Sattari Ghoshtasb   Pornaghshband Zahra   Aminorroaya Ashraf  

Gynecological Endocrinology, Vol. 24, Iss. 8, 2008-01 ,pp. : 423-427

Informa Healthcare

Access to resources Recommend Favorite

Hyperinsulinaemia and polycystic ovary syndrome

By Conway Gerard  

Human Fertility, Vol. 3, Iss. 2, 2000-05 ,pp. : 93-95

Informa Healthcare

Access to resources Recommend Favorite

Definition of polycystic ovary syndrome

By Dewailly Didier  

Human Fertility, Vol. 3, Iss. 2, 2000-05 ,pp. : 73-76

Informa Healthcare

Access to resources Recommend Favorite